Dimercaptosuccinic AcidDMSA (AnazaoHealth Corporation)
Welcome to the PulseAid listing for the Dimercaptosuccinic Acid drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AnazaoHealth Corporation |
NON-PROPRIETARY NAME: | Dimercaptosuccinic Acid |
SUBSTANCE NAME: | 2,3-DIMERCAPTOSUCCINIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2012-07-01 |
END MARKETING DATE: | 0000-00-00 |
Dimercaptosuccinic Acid DMSA HUMAN PRESCRIPTION DRUG Details:
Item Description | Dimercaptosuccinic Acid DMSA from AnazaoHealth Corporation |
LABELER NAME: | AnazaoHealth Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1.1(mg/1) |
START MARKETING DATE: | 2012-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51808-211_ec657ecb-6327-464c-8aab-6d61a0546b83 |
PRODUCT NDC: | 51808-211 |
APPLICATION NUMBER: | |
Other 2,3-DIMERCAPTOSUCCINIC ACID Pharmaceutical Manufacturers / Labelers: